Costs for heart failure with normal vs reduced ejection fraction

被引:96
|
作者
Liao, L
Jollis, JG
Anstrom, KJ
Whellan, DJ
Kitzman, DW
Aurigemma, GP
Mark, DB
Schulman, KA
Gottdiener, JS
机构
[1] Duke Univ, Ctr Med, Durham, NC 27710 USA
[2] Duke Clin Res Inst, Durham, NC 27710 USA
[3] Jefferson Heart Inst, Philadelphia, PA USA
[4] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[5] Univ Massachusetts, Med Ctr, Worcester, MA USA
[6] Univ Maryland, Sch Med, Baltimore, MD USA
关键词
D O I
10.1001/archinte.166.1.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Among the elderly population, heart failure (HF) with normal ejection fraction (EF) is more common than classic HF with low EF. However, there are few data regarding the costs of HF with normal EF. In a prospective, population-based cohort of elderly participants, we compared the costs and resource use of patients with HF and normal and reduced EF. Methods: A total of 4549 participants (84.5% white; 40.6% male) in the National Heart, Lung, and Blood Institute Cardiovascular Health Study were linked to Medicare claims from 1992 through 1998. By protocol echo examinations or clinical EF assessments, 881 participants with HF were characterized,as having abnormal or normal EF. We applied semiparametric estimators to calculate mean costs per subject for a 5-year period. Results: There were 495 HF participants with normal EF (186 prevalent at study entry and 309 incident during the study period) and 386 participants with abnormal EF (166 prevalent and 220 incident). Participants with abnormal EF had more cardiology encounters and cardiac procedures. However, compared with abnormal EF participants, the 5-year costs for normal EF participants were similar in both the prevalent ($33 023 with abnormal EF and $32 580 with normal EF; P=.93) and incident ($49 128 with abnormal EF and $45 604 with normal EF; P=.55) groups. In models accounting for comorbid conditions, the costs with normal and abnormal EF remained similar. Conclusions: Over a 5-year period, patients with HF and normal EF consume as many health care resources as those with reduced EF. These data highlight the substantial financial burden of HF with normal EF among the elderly population.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 50 条
  • [31] Vericiguat for Heart Failure with Reduced Ejection Fraction
    Lombardi, Carlo Mario
    Cimino, Giuliana
    Pagnesi, Matteo
    Dell'Aquila, Andrea
    Tomasoni, Daniela
    Ravera, Alice
    Inciardi, Riccardo
    Carubelli, Valentina
    Vizzardi, Enrico
    Nodari, Savina
    Emdin, Michele
    Aimo, Alberto
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (10)
  • [32] Redefining Heart Failure With a Reduced Ejection Fraction
    Butler, Javed
    Anker, Stefan D.
    Packer, Milton
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (18): : 1761 - 1762
  • [33] Sarcopenia in heart failure with reduced ejection fraction
    Canteri, Andre L.
    Gusmon, Luana B.
    Zanini, Ana C.
    Nagano, Francisca E.
    Rabito, Estela I.
    Petterle, Ricardo R.
    Jonasson, Thaisa H.
    Boguszewski, Cesar L.
    Borba, Victoria Z. C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2019, 9 (06): : 116 - 126
  • [34] Vericiguat in Heart Failure with Reduced Ejection Fraction
    Wearden, Jessica
    Hough, Augustus
    Kaiser, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1496 - 1497
  • [35] Vericiguat for Heart Failure with Reduced Ejection Fraction
    Carlo Mario Lombardi
    Giuliana Cimino
    Matteo Pagnesi
    Andrea Dell’Aquila
    Daniela Tomasoni
    Alice Ravera
    Riccardo Inciardi
    Valentina Carubelli
    Enrico Vizzardi
    Savina Nodari
    Michele Emdin
    Alberto Aimo
    Current Cardiology Reports, 2021, 23
  • [36] Management of heart failure with reduced ejection fraction
    Haydock, Paul M.
    Flett, Andrew S.
    HEART, 2022, 108 (19) : 1571 - 1579
  • [37] Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction
    Fukuta, Hidekatsu
    Little, William C.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2007, 49 (04) : 229 - 240
  • [38] TOTAL AND CAUSE-SPECIFIC HEALTHCARE COSTS FOLLOWING HOSPITALIZATION FOR HEART FAILURE WITH REDUCED VS MILDLY REDUCED/PRESERVED EJECTION FRACTION
    Kittipibul, Veraprapas
    Vaduganathan, Muthiah
    Fonarow, Gregg C.
    Ikeaba, Uchechukwu
    Chiswell, Karen E.
    Butler, Javed
    Huang, Joanna
    Kittleson, Michelle Maya
    Linganathan, Karthik
    McDermott, James
    Owens, Anjali Tiku
    Peterson, Pamela N.
    Solomon, Scott D.
    Vardeny, Orly
    Greene, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 284 - 284
  • [39] Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
    Liu, Dan
    Hu, Kai
    Schregelmann, Lena
    Hammel, Clara
    Lengenfelder, Bjorn Daniel
    Ertl, Georg
    Frantz, Stefan
    Nordbeck, Peter
    ESC HEART FAILURE, 2023, 10 (02): : 1358 - 1371
  • [40] Treatment of heart failure with normal ejection fraction
    Hamdani N.
    Paulus W.J.
    Current Treatment Options in Cardiovascular Medicine, 2011, 13 (1) : 26 - 34